PL3842047T3 - Kompozycje hialuronanu o wysokiej elastyczności i sposoby ich zastosowania - Google Patents
Kompozycje hialuronanu o wysokiej elastyczności i sposoby ich zastosowaniaInfo
- Publication number
- PL3842047T3 PL3842047T3 PL21156772.2T PL21156772T PL3842047T3 PL 3842047 T3 PL3842047 T3 PL 3842047T3 PL 21156772 T PL21156772 T PL 21156772T PL 3842047 T3 PL3842047 T3 PL 3842047T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- high elasticity
- hyaluronan compositions
- hyaluronan
- compositions
- Prior art date
Links
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 title 1
- 229940099552 hyaluronan Drugs 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562232364P | 2015-09-24 | 2015-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3842047T3 true PL3842047T3 (pl) | 2024-10-28 |
Family
ID=57121519
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21156772.2T PL3842047T3 (pl) | 2015-09-24 | 2016-09-21 | Kompozycje hialuronanu o wysokiej elastyczności i sposoby ich zastosowania |
| PL16778947T PL3352766T3 (pl) | 2015-09-24 | 2016-09-21 | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16778947T PL3352766T3 (pl) | 2015-09-24 | 2016-09-21 | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10383889B2 (pl) |
| EP (3) | EP4474011A3 (pl) |
| JP (3) | JP6948716B2 (pl) |
| CN (2) | CN108135926A (pl) |
| ES (2) | ES2871199T3 (pl) |
| HU (2) | HUE054874T2 (pl) |
| PL (2) | PL3842047T3 (pl) |
| PT (2) | PT3842047T (pl) |
| RU (2) | RU2020123728A (pl) |
| WO (1) | WO2017053339A1 (pl) |
| ZA (1) | ZA202007149B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180042978A1 (en) * | 2008-04-10 | 2018-02-15 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus |
| EP3613423B1 (en) | 2013-07-10 | 2022-10-26 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
| CN108135926A (zh) | 2015-09-24 | 2018-06-08 | 基质生物研究所 | 高弹性透明质酸组合物及其使用方法 |
| JP7229262B2 (ja) * | 2017-11-22 | 2023-02-27 | ボシュ・アンド・ロム・インコーポレイテッド | 眼科用粘弾性組成物 |
| WO2019202017A1 (en) | 2018-04-18 | 2019-10-24 | i.com medical GmbH | High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease |
| US20200030226A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Consumer Inc. | Botanical and bacterial extracts displaying retinol-like activity |
| JP7374986B2 (ja) | 2018-07-27 | 2023-11-07 | ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド | 眼を治療するための組成物及び方法 |
| US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US12268706B2 (en) | 2019-01-31 | 2025-04-08 | i.com medical GmbH | Hyaluronic acid for relief of idiopathic ocular pain |
| US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| ES2837548B2 (es) * | 2019-12-31 | 2022-04-18 | Univ Miguel Hernandez De Elche Umh | Procedimiento y dispositivo para producir una secreción lagrimal refleja y un kit para la medición de la magnitud de flujo lagrimal generado |
| CN111617313B (zh) * | 2020-04-29 | 2022-09-06 | 天津医科大学眼科医院 | 一种眼用线性凝胶在作为临床孔源性视网膜脱离药物方面中的应用 |
| US20230241096A1 (en) * | 2020-06-12 | 2023-08-03 | i.com medical GmbH | High molecular weight hyaluronic acid for use in the treatment of corneal nerve damage or loss |
| IT202000025264A1 (it) | 2020-10-26 | 2022-04-26 | Innate S R L | Composizione iniettabile comprendente acido ialuronico e uso della detta composizione. |
| US12397017B2 (en) | 2022-01-12 | 2025-08-26 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
| US11951123B2 (en) | 2022-01-12 | 2024-04-09 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
Family Cites Families (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4141973A (en) | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| US4407791A (en) | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4517295A (en) | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
| IE57931B1 (en) | 1983-10-11 | 1993-05-19 | Fidia Spa | Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same |
| IT1198449B (it) | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | Esteri di alcoli polivalenti di acido ialuronico |
| AU620821B2 (en) | 1987-08-25 | 1992-02-27 | Macnaught Pty Limited | Hyaluronic acid lubricating compounds |
| US5403592A (en) | 1987-08-25 | 1995-04-04 | Macnaught Pty Limited | Lubricant composition for rheumatism |
| EP0414373B2 (en) * | 1989-07-24 | 2001-04-25 | Allergan Pharmaceuticals (Ireland) Limited | Stable solution of hyaluronate in a balanced salt medium |
| AU652022B2 (en) | 1991-02-12 | 1994-08-11 | C.R. Bard Inc. | Injectable medical device |
| US5234914A (en) | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
| AU682670B2 (en) | 1993-02-05 | 1997-10-16 | Becton Dickinson & Company | Syringe needle isolation device |
| US5624915A (en) | 1993-08-04 | 1997-04-29 | Patent Biopharmaceutics, Inc. | Hyaluronic acid-urea pharmaceutical compositions and uses |
| US5607400A (en) | 1995-05-19 | 1997-03-04 | Becton, Dickinson And Company | Pre-fillable syringe and stopper assembly therefor |
| IT1277707B1 (it) | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
| JPH09173450A (ja) | 1995-12-26 | 1997-07-08 | Nissho Corp | プレフィルドシリンジ |
| JP3293122B2 (ja) | 1996-12-13 | 2002-06-17 | ニプロ株式会社 | プレフィルドシリンジ |
| SE9700827D0 (sv) | 1997-03-07 | 1997-03-07 | Pharmacia & Upjohn Ab | Ophthalmic composition |
| RU2126669C1 (ru) | 1997-04-25 | 1999-02-27 | Новокузнецкий государственный институт усовершенствования врачей | Способ лечения синдрома сухого глаза |
| SE9703425D0 (sv) | 1997-09-23 | 1997-09-23 | Pharmacia & Upjohn Ab | Prefilled ampooules and manufacture thereof |
| DE19751219A1 (de) | 1997-11-19 | 1999-05-27 | Vetter & Co Apotheker | Spritze, insbesondere vorgefüllte Spritze, oder Karpule |
| EP2253548A1 (en) | 1998-03-13 | 2010-11-24 | Becton, Dickinson and Company | Method for manufacturing, filling and packaging medical containers |
| ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| JP3591636B2 (ja) | 2000-04-03 | 2004-11-24 | ニプロ株式会社 | プレフィルドシリンジ |
| ATE250924T1 (de) | 2000-04-07 | 2003-10-15 | Medidom Lab | Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel |
| US7635489B2 (en) * | 2001-05-18 | 2009-12-22 | Leneau Holdings, Llc | Ingestion of hyaluronic acid for improved joint health |
| JP2003119147A (ja) | 2001-10-10 | 2003-04-23 | Raku:Kk | ヒアルロン酸化合物の水溶液組成物 |
| WO2003043660A2 (en) * | 2001-11-21 | 2003-05-30 | Novartis Ag | Composition for stabilizing hyaluronic acid |
| US7820194B2 (en) | 2001-12-21 | 2010-10-26 | Alcon, Inc. | Combinations of viscoelastics for use during surgery |
| JP4141156B2 (ja) | 2002-03-15 | 2008-08-27 | 日本ベクトン・ディッキンソン株式会社 | プランジャ後退制限機構付きプレフィルドシリンジ |
| US7081107B2 (en) | 2002-07-02 | 2006-07-25 | Terumo Kabushiki Kaisha | Syringe and prefilled syringe |
| CN102178692A (zh) | 2002-07-03 | 2011-09-14 | 派瑞克科学公司 | 透明质酸组合物以及使用方法 |
| EP1551399A4 (en) | 2002-09-30 | 2011-01-05 | Mark A Babizhayev | METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT |
| DE10254321A1 (de) | 2002-11-21 | 2004-06-17 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Vorgefüllte Spritze |
| EP1972344A1 (en) * | 2002-12-20 | 2008-09-24 | Chakshu Research, Inc. | Ophthalmic formulation for the prevention and treatment of ocular conditions |
| JP2004229750A (ja) | 2003-01-28 | 2004-08-19 | Nipro Corp | プレフィルドシリンジ及びそのバレルの製造方法 |
| US20040167480A1 (en) | 2003-02-21 | 2004-08-26 | Advanced Medical Optics, Inc. | Administration of multiple viscoelastic solutions with a multi-compartment syringe |
| JP2004262777A (ja) | 2003-02-27 | 2004-09-24 | Shiseido Co Ltd | アセチル化ヒアルロン酸含有眼用医薬組成物 |
| FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
| AR044302A1 (es) | 2003-05-13 | 2005-09-07 | Ares Trading Sa | Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos |
| US20050059639A1 (en) | 2003-09-11 | 2005-03-17 | Wei Edward T. | Ophthalmic compositions and method for treating eye discomfort and pain |
| US20050075611A1 (en) | 2003-10-01 | 2005-04-07 | Hetzler Kevin G. | Low extractable, thermoplastic syringe and tip cap |
| US20090148527A1 (en) | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
| JP2007536277A (ja) | 2004-05-07 | 2007-12-13 | エスケイ ファーマシューティカルズ インコーポレイテッド | 安定化されたヒアルロナン調製物及びその方法 |
| US8372814B2 (en) | 2004-06-07 | 2013-02-12 | Ista Pharmaceuticals, Inc. | Ophthalmic formulations and uses thereof |
| CN101094680A (zh) | 2004-12-30 | 2007-12-26 | 建新公司 | 用于关节内粘弹性补充的方案 |
| US8388995B1 (en) | 2006-02-03 | 2013-03-05 | Auburn University | Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform |
| US9238003B2 (en) | 2005-02-04 | 2016-01-19 | Auburn University | Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules |
| ITPD20050056A1 (it) | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
| US7767710B2 (en) | 2005-05-25 | 2010-08-03 | Calosyn Pharma, Inc. | Method for treating osteoarthritis |
| DE102005055275A1 (de) * | 2005-11-17 | 2007-05-24 | Ursapharm Arzneimittel Gmbh & Co. Kg | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| US8039447B2 (en) | 2005-11-22 | 2011-10-18 | Centre National De La Recherche Scientifique (C.N.R.S.) | Derivatives of hyaluronic acid, their preparation process and their uses |
| US7988675B2 (en) | 2005-12-08 | 2011-08-02 | West Pharmaceutical Services Of Delaware, Inc. | Automatic injection and retraction devices for use with pre-filled syringe cartridges |
| WO2007070547A2 (en) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| JP4682850B2 (ja) | 2006-01-12 | 2011-05-11 | ニプロ株式会社 | プレフィルドシリンジ |
| AU2007208054A1 (en) | 2006-01-25 | 2007-08-02 | Aciex Therapeutics, Inc. | Formulations and methods for treating dry eye |
| US7674781B2 (en) | 2006-04-28 | 2010-03-09 | Heather Sheardown | Hyaluronic acid-retaining polymers |
| WO2008011836A2 (es) | 2006-07-25 | 2008-01-31 | Osmotica Corp. | Soluciones oftálmicas |
| BRPI0716270A2 (pt) * | 2006-08-28 | 2013-08-13 | Rexaderm Inc | bandagem de ferida seca e sistema de distribuiÇço de fÁrmaco |
| ITMI20061668A1 (it) | 2006-09-01 | 2008-03-02 | Schiena Michele Giuseppe Di | Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali |
| JP2010510347A (ja) | 2006-11-17 | 2010-04-02 | エージェンシー フォー サイエンス， テクノロジー アンド リサーチ | 架橋性湿潤剤を有する多孔質ポリマー材料 |
| BRPI0621470A2 (pt) | 2006-12-05 | 2011-12-13 | Glycoscience Lab Inc | agente terapêutico para artrite degenerativa |
| FR2918276B1 (fr) | 2007-07-02 | 2010-01-22 | Anteis Sa | "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires" |
| JP2009196903A (ja) | 2008-02-19 | 2009-09-03 | Lion Corp | 眼科用組成物 |
| WO2009111159A2 (en) | 2008-03-03 | 2009-09-11 | New York University | Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same |
| AU2009231634B2 (en) | 2008-04-04 | 2014-05-15 | University Of Utah Research Foundation | Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
| FR2938187B1 (fr) * | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
| WO2010078648A1 (en) | 2009-01-07 | 2010-07-15 | Robert John Petrella | Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
| US20100178317A1 (en) | 2009-01-09 | 2010-07-15 | Burke Susan E | Lens Care Solutions with Hyaluronic Acid |
| US8979821B2 (en) | 2009-04-14 | 2015-03-17 | Fezza Family Properties, Llc | Lacrimal filler |
| US20100303915A1 (en) | 2009-06-02 | 2010-12-02 | Abbott Medical Optics Inc. | Therapeutic opthalmic emulsions |
| SG176679A1 (en) | 2009-06-05 | 2012-01-30 | Edward Tak Wei | Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid |
| US8673340B2 (en) | 2009-09-10 | 2014-03-18 | Boston Foundation For Sight | Sodium channel blocker delivery system with scleral lens |
| EP2485754A1 (en) * | 2009-10-07 | 2012-08-15 | Genogen, Inc. | Methods and compositions for skin regeneration |
| EP2316420B1 (en) * | 2009-10-22 | 2014-02-26 | Consorzio Universitario Unifarm | Topical ophthalmic composition to reduce pain |
| US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| DK2550027T4 (da) * | 2010-03-22 | 2019-05-13 | Allergan Inc | Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse |
| US20130209531A1 (en) | 2010-06-08 | 2013-08-15 | University Of Utah Research Foundation | Applications of partially and fully sulfated hyaluronan |
| CA2809893A1 (en) | 2010-09-02 | 2012-03-08 | Mcmaster University | Hyaluronic acid-containing biopolymers |
| CA2810481C (en) | 2010-09-10 | 2018-06-19 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof |
| JP6047272B2 (ja) | 2010-09-15 | 2016-12-21 | テイカ製薬株式会社 | 角膜上皮障害治療用点眼剤 |
| US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
| US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
| BR112013025493A2 (pt) * | 2011-04-05 | 2017-03-01 | Optsolve Llp | composição aquosa administrável de maneira tópica a um olho humano ou animal, método para tratar uma afecção que envolve deficiências em lágrimas naturais no olho humano ou animal, composição para aplicação tópica no tratamento de um distúrbio ou afecção ocular do olho humano ou animal, método para tratar um distúrbio ou afecção ocular do olho humano ou animal, composição para uso no tratamento de dor associada ao olho humano ou animal e método para alívio da dor no olho humano ou animal ou próximo ao mesmo |
| US20140038917A1 (en) * | 2011-04-19 | 2014-02-06 | Anteis S.A. | Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint |
| GB201118586D0 (en) | 2011-10-27 | 2011-12-07 | Turzi Antoine | New A-PRP medical device, manufacturing machine and process |
| EP2596796B1 (en) * | 2011-11-24 | 2013-11-13 | Quimera Ingenieria Biomedica, S.L. | Complex obtained from hyaluronic acid or a salt thereof and chondroitin sulphate mixtures |
| JP2015508104A (ja) | 2012-02-22 | 2015-03-16 | トラスティーズ オブ タフツ カレッジ | 治療薬の眼への送達のための組成物および方法 |
| JPWO2013125634A1 (ja) | 2012-02-22 | 2015-07-30 | 株式会社ヒアルロン酸研究所 | ヒアルロン酸フラグメントを有効成分とするサーチュイン誘導剤、組織修復剤、肝細胞増殖因子誘導剤、組織恒常性維持剤、及びｔｌｒ４作用剤 |
| UA113434C2 (uk) | 2012-05-04 | 2017-01-25 | Алкон Рісерч, Лтд. | Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням |
| FR2991876B1 (fr) * | 2012-06-13 | 2014-11-21 | Vivacy Lab | Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate |
| FR2994846B1 (fr) * | 2012-08-29 | 2014-12-26 | Vivacy Lab | Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium |
| EP2950783B1 (en) | 2013-02-01 | 2019-05-15 | Allergan, Inc. | Artificial tears comprising sodium hyaluronate and carboxymethylcellulose |
| US9226938B2 (en) | 2013-03-14 | 2016-01-05 | RMG Rehabilitation Management Group, LP | Combinatorial therapy for treatment of osteoarthritis of the knee |
| SG11201507724UA (en) | 2013-03-25 | 2015-10-29 | Univ Tokyo Nat Univ Corp | Plant cultivation method |
| ITMI20130883A1 (it) * | 2013-05-30 | 2014-12-01 | Eurores S R L | Composizioni farmaceutiche comprendenti collagene e sodio ialuronato |
| EP3613423B1 (en) * | 2013-07-10 | 2022-10-26 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
| CA2931039C (en) | 2013-11-20 | 2022-07-12 | Mary Lynch | Compositions and methods for treatment of ocular inflammation and pain |
| EP3074427B1 (en) | 2013-11-25 | 2021-01-06 | Deuteria Biomaterials, LLC | Deuterium-enriched hyaluronan |
| FR3015290B1 (fr) | 2013-12-23 | 2017-01-13 | Lab Vivacy | Compositions d'acide hyaluronique compreant de la mepivacaine |
| CN108135926A (zh) | 2015-09-24 | 2018-06-08 | 基质生物研究所 | 高弹性透明质酸组合物及其使用方法 |
-
2016
- 2016-09-21 CN CN201680055675.3A patent/CN108135926A/zh active Pending
- 2016-09-21 EP EP24190459.8A patent/EP4474011A3/en active Pending
- 2016-09-21 RU RU2020123728A patent/RU2020123728A/ru unknown
- 2016-09-21 ES ES16778947T patent/ES2871199T3/es active Active
- 2016-09-21 ES ES21156772T patent/ES2990076T3/es active Active
- 2016-09-21 PT PT211567722T patent/PT3842047T/pt unknown
- 2016-09-21 US US15/271,434 patent/US10383889B2/en active Active
- 2016-09-21 EP EP21156772.2A patent/EP3842047B1/en active Active
- 2016-09-21 HU HUE16778947A patent/HUE054874T2/hu unknown
- 2016-09-21 PL PL21156772.2T patent/PL3842047T3/pl unknown
- 2016-09-21 RU RU2018114926A patent/RU2727809C2/ru active
- 2016-09-21 JP JP2018515260A patent/JP6948716B2/ja active Active
- 2016-09-21 PT PT167789478T patent/PT3352766T/pt unknown
- 2016-09-21 WO PCT/US2016/052743 patent/WO2017053339A1/en not_active Ceased
- 2016-09-21 HU HUE21156772A patent/HUE068774T2/hu unknown
- 2016-09-21 EP EP16778947.8A patent/EP3352766B1/en active Active
- 2016-09-21 PL PL16778947T patent/PL3352766T3/pl unknown
- 2016-09-21 CN CN202110969702.0A patent/CN113577097A/zh active Pending
-
2019
- 2019-07-02 US US16/460,557 patent/US10888580B2/en active Active
-
2020
- 2020-11-17 ZA ZA2020/07149A patent/ZA202007149B/en unknown
- 2020-12-08 US US17/115,242 patent/US11583549B2/en active Active
-
2021
- 2021-07-09 JP JP2021114150A patent/JP2021165311A/ja not_active Withdrawn
-
2023
- 2023-08-28 JP JP2023137928A patent/JP2023153417A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP3352766A1 (en) | 2018-08-01 |
| JP6948716B2 (ja) | 2021-10-13 |
| WO2017053339A1 (en) | 2017-03-30 |
| CN113577097A (zh) | 2021-11-02 |
| RU2018114926A3 (pl) | 2019-10-24 |
| HUE068774T2 (hu) | 2025-01-28 |
| ES2871199T3 (es) | 2021-10-28 |
| PL3352766T3 (pl) | 2021-08-02 |
| US10888580B2 (en) | 2021-01-12 |
| EP4474011A2 (en) | 2024-12-11 |
| US11583549B2 (en) | 2023-02-21 |
| EP3352766B1 (en) | 2021-03-17 |
| US20170087177A1 (en) | 2017-03-30 |
| EP3842047B1 (en) | 2024-08-07 |
| ES2990076T3 (es) | 2024-11-28 |
| RU2020123728A (ru) | 2021-01-18 |
| RU2727809C2 (ru) | 2020-07-24 |
| EP4474011A3 (en) | 2025-02-26 |
| US20210085709A1 (en) | 2021-03-25 |
| CN108135926A (zh) | 2018-06-08 |
| JP2023153417A (ja) | 2023-10-17 |
| HK1250657A1 (zh) | 2019-01-11 |
| EP3842047A1 (en) | 2021-06-30 |
| US10383889B2 (en) | 2019-08-20 |
| HUE054874T2 (hu) | 2021-10-28 |
| RU2018114926A (ru) | 2019-10-24 |
| ZA202007149B (en) | 2025-04-30 |
| PT3352766T (pt) | 2022-03-22 |
| US20200030364A1 (en) | 2020-01-30 |
| PT3842047T (pt) | 2024-09-19 |
| JP2021165311A (ja) | 2021-10-14 |
| JP2018529691A (ja) | 2018-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286316A (en) | New micro-dystrophins and related method of use | |
| IL274276A (en) | CASZ preparations and methods of use | |
| GB2582100B (en) | CAS12C Compositions and methods of use | |
| PT3352766T (pt) | Composições de hialuronano de elevada elasticidade e processos para o seu uso | |
| ZA201801511B (en) | Flavonoid compositions and methods of use | |
| ZA201707981B (en) | Compositions of obeticholic acid and methods of use | |
| IL257307B (en) | Transgenic crispr–cas9 preparations and methods of use | |
| ZA201702794B (en) | Cellulose-containing compositions and methods of making same | |
| SG11201707876YA (en) | Microalgal compositions and uses thereof | |
| ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
| ZA201906169B (en) | Synthekine compositions and methods of use | |
| SI3194564T1 (sl) | Sestavki trichoderme in postopki uporabe | |
| SG11201708114SA (en) | Ophthalmic compositions and methods of use therefor | |
| SI3288379T1 (sl) | Peptidne sestave in načini uporabe | |
| EP3190886A4 (en) | Compositions and methods of use thereof | |
| IL256843B (en) | Cleaning products and methods of using them | |
| SG11201803284YA (en) | Novel method of use and compositions | |
| IL246711A0 (en) | Biologically active haloperoxidase compositions and methods of using them | |
| EP3207029A4 (en) | Tryptamide compositions and methods of use | |
| IL261794A (en) | Preparations and methods for using them | |
| IL247645A0 (en) | Preparations of seleno-organic compounds and methods of using them | |
| AU2014905067A0 (en) | Compositions and methods of use | |
| AU2014902829A0 (en) | Compositions and Methods of Use |